Illness experience of Gulf War veterans possibly exposed to chemical warfare agents

American Journal of Preventive Medicine

Volumn 23, Issue 3, 2002, Pages 200-206

  McCauley, Linda A ^a   Lasarev, Michael ^a   Sticker, Diana ^a   Rischitelli, D Gary ^a   Spencer, Peter S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chemical warfare agents; Cholinesterase inhibitors; Diagnosis; Disease; Morbidity; Persian Gulf syndrome

Indexed keywords

CHEMICAL WARFARE AGENT;

ADULT; ARTICLE; CANCER; CHEMICAL WARFARE; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH STATUS; HEALTH SURVEY; HEART DISEASE; HOSPITALIZATION; HUMAN; HYPERTENSION; INTERVERTEBRAL DISK HERNIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIODONTAL DISEASE; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; SOLDIER; TELEPHONE; UNITED STATES;

CHEMICAL WARFARE AGENTS; DATA INTERPRETATION, STATISTICAL; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH STATUS; HUMANS; IRAQ; MALE; PREVALENCE; QUESTIONNAIRES; UNITED STATES; VETERANS; WAR;

EID: 0036805605     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(02)00497-X     Document Type: Article

References (47)

1. Iowa Persian Gulf Study Group . Self-reported illness and health status among Gulf War Veterans. JAMA. 277:1997;238-245.
2. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention . Unexplained illness among Persian Gulf War veterans in an Air National Guard unit: preliminary report August 1990-March 1995. MMWR Morb Mort Wkly Rep. 44:1995;443-447.
3. Unwin C., Blatchley N., Coker W., et al. Health of U.K. servicemen who served in Persian Gulf War. Lancet. 353:1999;169-178.
4. Gulf War Illness Advisory Committee . Health Study of Canadian Forces Personnel Involved in the 1991 Conflict in the Persian Gulf. Volume I. 1998;Department of National Defense, Ottawa, Ontario.
5. Kang H.K., Mahan C.M., Lee K.Y., Magee C.A., Murphy F.M. Illnesses among United States veterans of the Gulf War a population-based survey of 30,000 veterans . J Occup Environ Med. 42:2000;491-501.
6. Gray G.C., Coate B.C., Anderson C.M., et al. The postwar hospitalization experience of U.S. veterans of the Persian Gulf War. N Engl J Med. 335:1996;1505-1513.
7. Gray G., Smith T., Knoke J., Heller J. The postwar hospitalization experience of Gulf War veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq. Am J Epidemiol. 150:1999;532-540.
8. Kang H. VA Data Sources Experiences from the Registry and Mortality Study . 1997;Persian Gulf Research Federal Investigator's Meeting, Fort Detrick, Frederick, MD.
9. Gray G., Smith T., Kang H., Knoke J. Are Gulf War veterans suffering war-related illnesses? Federal and civilian hospitalizations examined, June 1991 to December 1994. Am J Epidemiol. 151:2000;63-71.
10. MacFarlane G.J., Thomas E., Cherry N. Mortality among UK Gulf War veterans. Lancet. 356:2000;17-21.
11. Haley R.W., Hom J., Roland P.S., et al. Evaluation of neurologic function in Gulf War veterans. JAMA. 277:1997;223-230.
12. Mathews J. Panel urges further research on Gulf war illness, possible increased cancer risks in veterans. J Natl Cancer Inst. 86:1994;820-822.
13. Cannova J.V. Multiple giant cell tumors in a patient with Gulf War syndrome. Mil Med. 163:1998;184-185.
14. Murphy F., Browne D., Mather S., Scheele H., Hyams K.C. Women in the Persian Gulf war health care implications for active duty troops and veterans . Mil Med. 162:1997;656-660.
15. Sutker P.B., Uddo M., Brailey K., Allain A.N., Erera P. Psychological symptoms and psychiatric diagnoses in Operation Desert Storm troops serving Graves registration duty. J Trauma Stress. 7:1994;159-171.
16. Knoke J.D., Gray G.C. Hospitalizations for unexplained illnesses among U.S. veterans of the Persian Gulf War. Emerg Infect Dis. 4:1998;211-219.
17. Chan K.C. Gulf War Veterans - Limitation as of Available Data for Accurately Determining the Incidence of Tumors. 1998;Government Accounting Office, Washington, DC. (GAO/T-NSIAD-98-186).
18. Koenigsberg EJ, Moldenhauer ET. Director, Persian Gulf Veterans' Illnesses Investigation Team, Department of Defense, testimony before the Presidential Advisory Committee on the Gulf War veterans' illnesses, August 6, 1996. Available at: www.gulflink.osd.mil/testimony/pac06aug.html. Accessed April 1, 1999.
19. Martin, JE. Deputy Director, Persian Gulf Veterans' Illnesses Investigation Team, Department of Defense, testimony before the Presidential Advisory Committee on Gulf War veterans' illnesses, May 1, 1996. Available at: www.gulflink.osd.mil/testimony/pacmay1r.htm. Accessed April 1, 1999.
20. McCauley L., Rischitelli G., Lambert W., Lasarev M., Sticker D., Spencer P. Symptoms of Gulf war veterans possibly exposed to organophosphate chemical warfare agents at Khamisiyah, Iraq. Int J Occup Environ Health. 7:2001;79-89.
21. Spencer P.S., McCauley L.A., Joos L.A., et al. U.S. Gulf War veterans service periods in theater, differential exposures and persistent unexplained illness . Toxicol Lett. 102:1998;515-521.
22. McCauley L.A., Joos S.K., Lasarev M.R., Storzbach D., Bourdette D.N., members of Portland Environmental Hazards Research Center . Gulf War unexplained illness persistence and unexplained nature of self-reported symptoms . Environ Res. 81:1999;215-223.
23. McCauley L.A., Joos S.K., Spencer P.S., Lasarev M., Shuell T., members of Portland Environmental Hazards Research Center . Strategies to assess validity of self-reported exposures during the Persian Gulf War. Environ Res. 81:1999;195-205.
24. Steele L. Prevalence and patterns of Gulf War illness in Kansas veterans association of symptoms with characteristics of person, place, and time of military service . Am J Epidemiol. 152:2000;992-1002.
25. DeFraites R.F., Wanat E.R., Norwood A.E., William S., Cowan D., Callahan T. Investigation of a Suspected Outbreak of an Unknown Disease Among Veterans of Operation Desert Shield/Storm 123d Army Reserve command Fort Benjamin, Harrison, Indiana. 1992;Walter Reed Army Institute of Research, Washington, DC.
26. American Academy of Periodontology . The pathogenesis of periodontal diseases. J Periodontol. 70:1999;457-470.
27. Genco R.J., Ho A.W., Grossi S.G., Dunford R.G., Tedesco L.A. Relationship of stress, distress, and inadequate coping behaviors to periodontal disease. J Periodontal. 70:1999;711-723.
28. Genco R.F., Ho A.W., Kopman J., Grossi S.G., Dunford R.G., Tedesco L.A. Models to evaluate the role of stress in periodontal disease. Ann Periodontol. 3:1998;288-302.
29. Page R.C. Periodontal disease a new paradigm . J Dent Educ. 62:1998;812-821.
30. Garcia R.I., Krall E.A., Vakonas P.S. Periodontal disease and mortality from all causes in the VA Dental Longitudinal Study. Ann Periodontol. 3:1998;339-349.
31. Decoufle P., Holmgreen P., Calle E., Weeks M. Nonresponse and intensity of follow-up in an epidemiologic study of Vietnam-era veterans. Am J Epidemiol. 133:1991;83-95.
32. Walpole RD, 'Rostker B. Central Intelligence Agency and Department of Defense: modeling the chemical warfare agent release at the Khamisiyah pit, September 4, 1997. Available at: www.gulflink.osd.mil/cia_092297/. Accessed April 1, 1999.
33. Spencer P., Schaumburg H., Ludolph A. Experimental and Clinical Neurotoxicology. 2000;Oxford University Press, New York.
34. National Research Council . Possible long-term health effects of short-term exposure to chemical agents. Vol 1. Anticholinesterases and Anticholinergics. 1982;National Academy Press, Washington, DC.
35. National Research Council . Possible long-term health effects of short-term exposure to chemical agents. Vol 2. Cholinesterase Reactivators, Psychochemicals, and Irritants and Vesicants. 1984;National Academy Press, Washington, DC.
36. National Research Council . Possible long-term health effects of short-term exposure to chemical agents. Vol 3. Current health status of test subjects. 1985;National Academy Press, Washington, DC.
37. U.S. General Accounting Office . Gulf War illness improved monitoring of clinical progress and reexamination of research emphasis are needed . 1997;Government Accounting Office, Washington, DC. GAO/NSIAD-97-163).
38. Presidential Advisory Committee on Gulf War Veterans' Illnesses . Presidential Advisory Committee on Gulf War veterans' illnesses final report . 1996;U.S. Government Printing Office, Washington, DC.
39. Haley R.W., Kurt T.L. Self-reported exposure in neurotoxic chemical combinations in the Gulf War a cross-sectional epidemiological study. JAMA. 277:1997;231-237.
40. Wilson B.W., Henderson J.D., Spencer P.S. Clinical effects of low-level exposures to chemical warfare agents in mice and chickens. Drug Chem Toxicol. 21:1998;183-190.
41. Wolfe J., Proctor S.P., Davis J.D., Borgos M.S., Friedman M.J. Health symptoms reported by Persian Gulf War veterans two years after return. Am J Ind Med. 33:1998;104-113.
42. Olson C.T., Blank J.A., Menton R.G. Neuromuscular effects of low level exposures to sarin, pyridostigmine, DEET and chlorpyrifos. Drug Chem Toxicol. 2:1998;149-169.
43. Nakajima T., Ohta S., Fukushima Y., Yanagisawa N. Sequelae of sarin toxicity at one and three years after exposure in Matsumoto, Japan. J Epidemiol. 5:1999;337-343.
44. Murata K., Araki S., Yokoyama K., et al. Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack. J Neurol. 244:1997;601-606.
45. Brown T., Anderson L., Caldwell G.G. The Public Health Service role in the disposal of chemical munitions. Public Health Rep. 100:1985;374-378.
46. National Center for Environmental Health . Release of GB at the Tooele Chemical Agent Disposal Facility (TOCDF) on May 8-9, 2000. 2000;Centers for Disease Control and Prevention, Atlanta, GA.
47. Program Manager for Chemical Demilitarization. Joint United States-Russian Statement on Chemical Weapons. 1997. Available at: www.pmcd. apgea.army.mil/graphical/CTR/ctr_joint.html. Accessed April 1, 1999.